NCT06869551 A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis Status RECRUITING Phase PHASE3
NCT06855771 A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9) Status RECRUITING Phase PHASE2
NCT06853171 Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-release Trospium Chloride in Adolescents With Psychiatric Disorders Status COMPLETED Phase PHASE1
NCT06851871 A Study to Evaluate the Bioequivalence Between Immediate Release Tablets and Minitablets of Deucravacitinib (BMS-986165), and the Effect of Food and pH on the Drug Levels of the Minitablets in Healthy Adults Status COMPLETED Phase PHASE1
NCT06851065 A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States Status COMPLETED Phase N/A
NCT06846866 A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants Status COMPLETED Phase PHASE1
NCT06799286 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06788691 Luspatercept for Clonal Cytopenias of Uncertain Significance Status RECRUITING Phase PHASE2
NCT06773910 BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS) Status RECRUITING Phase PHASE2
NCT06767956 Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy Status WITHDRAWN Phase PHASE1/PHASE2
NCT06764771 A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors Status RECRUITING Phase PHASE1
NCT06756308 A Study of Enasidenib in People With T-Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06747845 Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy Status RECRUITING Phase PHASE2
NCT06746402 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants Status COMPLETED Phase PHASE1
NCT06735781 Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Chemotherapy in France Status COMPLETED Phase N/A
NCT06730750 A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06725537 Comprehensive Demographics and Clinical Profile of NSCLC Patients Status NOT_YET_RECRUITING Phase N/A
NCT06723535 A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis Status COMPLETED Phase PHASE1
NCT06715683 A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants Status COMPLETED Phase PHASE1